Comparison Between Effect of Conventional, Intensive and Light Emitting Diodes (LED) Phototherapy on Oxidative Stress Among Neonates With Unconjugated Hyperbilirubinemia
- Conditions
- Neonatal HyperbilirubinemiaOxidative StressPhototherapy Complication
- Interventions
- Procedure: phototherapy
- Registration Number
- NCT03074292
- Lead Sponsor
- Rania Ali El-Farrash
- Brief Summary
The aim of the present study is to test a hypothesis assuming that phototherapy might have an effect on oxidant/antioxidant status in term and late-preterm neonates with unconjugated hyperbilirubinemia.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 120
- Term and late-preterm neonates (≥35weeks) according to the guidelines of the American Academy of Pediatrics (2004) which stated that gestational ages of newborns were determined according to the first day of the mother's last menstrual period (by the mother's statement) and were additionally confirmed by the Ballard scoring system (Ballard et al., 1991) and antenatal ultrasonographic estimation or obstetric records if present.
- Clinical significant indirect hyperbilirubinemia requiring phototherapy in the first week of life.
- Normal blood counts and peripheral blood smears
- Normal reticulocytic count.
- Breast fed newborn.
- Those in whom the total serum bilirubin (TSB) level rose by more than 5 mg/dl per day or was higher than 20 mg/dl within the first 24 hours after birth were excluded from the study.
- Infant of diabetic mothers.
- Maternal eclampsia-preeclampsia.
- Birth asphyxia
- Sepsis
- congenital anomalies.
- Direct Coombs'test positive
- Pathological causes of hyperbilirubinemia.
- Enclosed hemorrhage.
- Hemolytic type of hyperbilirubinemia due to blood group or Rh incompatibility.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- FACTORIAL
- Arm && Interventions
Group Intervention Description conventional phototherapy phototherapy neonates with unconjugated hyperbilirubinemia exposed to conventional phototherapy extensive phototherapy phototherapy neonates with unconjugated hyperbilirubinemia exposed to extensive phototherapy LED phototherapy phototherapy neonates with unconjugated hyperbilirubinemia exposed to LED phototherapy
- Primary Outcome Measures
Name Time Method Effect of types of phototherapy on change in malonaldehyde (MDA) 2 days This will be determined by:
1. Measure MDA (nmol/L) before and after phototherapy
2. Compare results of MDA (nmol/L) before and after phototherapy.Effect of types of phototherapy on change in total antioxidant capacity (TAC) 2 days This will be determined by:
1. Measure TAC (mmol/L) before and after phototherapy
2. Compare results of TAC (mmol/L) before and after phototherapy.Effect of types of phototherapy on change in nitric oxide (NO) 2 days This will be determined by:
1. Measure NO (umol/L) before and after phototherapy
2. Compare results of NO (umol/L) before and after phototherapy.
- Secondary Outcome Measures
Name Time Method Effect of types of phototherapy on change in serum iron (Fe) 2 days This will be determined by:
1. Measure serum Fe before and after phototherapy
2. Compare results of serum Fe before and after phototherapy.Effect of types of phototherapy on change in serum calcium (Zn) 2 days This will be determined by:
1. Measure serum Ca before and after phototherapy
2. Compare results of serum Ca before and after phototherapy.Effect of types of phototherapy on change in serum zinc (Zn) 2 days This will be determined by:
1. Measure serum Zn before and after phototherapy
2. Compare results of serum Zn before and after phototherapy.Effect of types of phototherapy on change in serum copper (Cu) 2 days This will be determined by:
1. Measure serum Cu before and after phototherapy
2. Compare results of serum Cu before and after phototherapy.